Nitrogen

Description

Nitrogen, compressed NF, is a high-pressure gas classified under UN 1066 and identified by CAS number 7727-37-9. It is utilized in various medical applications, requiring a prescription for use. This gas is known to pose risks, including rapid suffocation, necessitating storage and usage in well-ventilated areas. Equipment must be rated for cylinder pressure, and the valve should be closed after each use and when the cylinder is empty. Administration of this gas mixture may be hazardous and is contraindicated in certain situations. It is intended for use only by or under the supervision of a licensed practitioner experienced in gas mixtures, who is knowledgeable about the indications, effects, dosages, methods, frequency, duration of administration, and associated hazards and precautions.

Uses and Indications

This drug is indicated for various medical applications as determined by a healthcare professional. It is available by prescription only.

There are no specific teratogenic or nonteratogenic effects associated with this drug.

Dosage and Administration

Administration of this gas mixture is indicated for specific medical applications and is available by prescription only. Due to the potential hazards associated with the use of this gas mixture, it is essential that it be administered only by or under the supervision of a licensed practitioner who possesses experience in the use and administration of gas mixtures.

The route of administration is via respiratory inhalation. The active ingredient in this formulation is nitrogen, comprising 99.2 mL in a 1 L mixture. Healthcare professionals should ensure that appropriate safety measures are in place during administration to mitigate any risks associated with inhalation of the gas mixture.

Contraindications

Administration of this gas mixture is contraindicated in patients who are not under the supervision of a licensed practitioner experienced in the use and administration of gas mixtures. Due to the potential hazards associated with high-pressure gas, including the risk of rapid suffocation, it is essential that this product is used only by qualified personnel who are familiar with its indications, effects, dosages, methods, and precautions.

Additionally, the use of this gas mixture is contraindicated in environments lacking adequate ventilation. Proper storage and handling must be ensured, including the use of equipment rated for cylinder pressure and the closure of the valve after each use or when empty. Compliance with the Material Safety Data Sheet (MSDS) is mandatory to mitigate risks associated with its use.

Warnings and Precautions

Administration of this gas mixture may pose significant hazards and is contraindicated in certain situations. It is intended for use solely by or under the supervision of a licensed practitioner who possesses experience in the use and administration of gas mixtures. Such practitioners must be well-versed in the indications, effects, dosages, methods, frequency, and duration of administration, as well as the associated hazards, contraindications, and necessary precautions.

General Precautions Caution is advised due to the high-pressure nature of the gas. The potential for rapid suffocation necessitates that this gas mixture be stored and utilized in environments with adequate ventilation. Equipment used must be rated for the cylinder pressure to ensure safety. It is imperative to close the valve after each use and when the cylinder is empty. All handling and usage should be conducted in accordance with the Material Safety Data Sheet (MSDS) to mitigate risks.

Monitoring Parameters While no specific laboratory tests are required for the safe use of this gas mixture, practitioners should remain vigilant and monitor patients for any adverse effects during administration.

In the event of any complications or unexpected reactions, immediate medical assistance should be sought. Practitioners are encouraged to maintain open lines of communication with patients regarding any concerns that may arise during treatment.

Side Effects

Administration of this gas mixture may pose significant hazards and is contraindicated in certain situations. It is intended for use solely by or under the supervision of a licensed practitioner who possesses experience in the use and administration of gas mixtures. Practitioners must be familiar with the indications, effects, dosages, methods, frequency, and duration of administration, as well as the associated hazards, contraindications, and necessary precautions.

Patients should be aware that this gas is classified as a high-pressure gas, which can lead to rapid suffocation if not handled properly. It is crucial to store and use the gas in an adequately ventilated area and to utilize equipment that is rated for the cylinder pressure. Practitioners are advised to close the valve after each use and when the cylinder is empty, and to follow the guidelines outlined in the Material Safety Data Sheet (MSDS) to ensure safe handling and administration.

Drug Interactions

No drug interactions or drug and laboratory test interactions have been identified for this product. Therefore, no specific recommendations for dosage adjustments or monitoring are necessary at this time.

Packaging & NDC

The table below lists all NDC Code configurations of Nitrogen, the U.S. brand-name prescription product. Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Pediatric Use

There is no specific pediatric use information available for this medication. The prescribing information does not include recommended ages, dosing differences, safety concerns, or special precautions for children. Healthcare professionals should exercise caution when considering the use of this medication in pediatric patients due to the absence of relevant data.

Geriatric Use

There is no specific information available regarding the use of this medication in geriatric patients, including dosage adjustments, safety concerns, or special precautions. Healthcare providers should exercise caution when prescribing this medication to elderly patients, as individual responses may vary. It is advisable to monitor these patients closely for any potential adverse effects or changes in efficacy.

Pregnancy

The safety and efficacy of this drug during pregnancy have not been established, as it has not been approved by the FDA. The administration of this gas mixture may pose potential hazards and is contraindicated in certain situations. Therefore, it is crucial that this drug is used only by or under the supervision of a licensed practitioner who has experience in the use and administration of gas mixtures. Pregnant patients should be counseled regarding the potential risks associated with the use of this drug, and alternative therapies should be considered when appropriate.

Lactation

The safety and efficacy of this drug have not been established by the FDA, and the labeling has not received FDA approval. The administration of this gas mixture may pose hazards and is contraindicated. Therefore, it is recommended that lactating mothers only use this drug under the supervision of a licensed practitioner who is experienced in the use and administration of gas mixtures. There is no available data regarding the excretion of this drug in breast milk or its effects on breastfed infants. Caution is advised when considering the use of this drug in lactating mothers.

Renal Impairment

There is no specific information regarding dosage adjustments, special monitoring, or safety considerations for patients with renal impairment. Healthcare professionals should exercise caution when prescribing to patients with reduced kidney function, as the absence of detailed guidance necessitates careful clinical judgment. Regular monitoring of renal function may be advisable in this patient population.

Hepatic Impairment

Patients with hepatic impairment have not been specifically studied in relation to the use of this medication. Consequently, there is no information available regarding dosage adjustments, special monitoring requirements, or precautions for individuals with compromised liver function. It is recommended that healthcare providers exercise caution when prescribing this medication to patients with hepatic impairment, given the lack of data on its safety and efficacy in this population.

Overdosage

Administration of this gas mixture may pose significant risks and is contraindicated in certain situations. It is imperative that this gas mixture is utilized solely by or under the supervision of a licensed practitioner. The practitioner must possess experience in the use and administration of gas mixtures, as well as a comprehensive understanding of the indications, effects, dosages, methods, and frequency and duration of administration.

In the event of overdosage, healthcare professionals should be vigilant for potential adverse effects associated with excessive exposure to the gas mixture. Symptoms may vary depending on the specific gas components and the extent of overexposure.

Management of overdosage should include immediate cessation of administration and supportive care tailored to the symptoms presented. It is crucial for healthcare providers to monitor the patient closely and implement appropriate interventions based on clinical judgment and established protocols.

Practitioners are advised to remain aware of the hazards and contraindications associated with this gas mixture, ensuring that all necessary precautions are taken to mitigate risks during administration.

Nonclinical Toxicology

No teratogenic or non-teratogenic effects have been reported in the available nonclinical studies. Additionally, there is no information regarding animal pharmacology and toxicology. The absence of data limits the assessment of potential risks associated with the use of the compound in these contexts.

Postmarketing Experience

Postmarketing experience has indicated that the administration of this gas mixture may be hazardous and is contraindicated. Additionally, it is important to note that this drug has not been found by the FDA to be safe and effective, and the labeling has not received FDA approval.

Patient Counseling

Healthcare providers should advise patients about the potential hazards associated with the use of high-pressure gas. It is crucial to inform patients that this gas can cause rapid suffocation and that it should be stored and used in areas with adequate ventilation to minimize risks.

Patients should be instructed to use equipment that is rated for the specific cylinder pressure to ensure safety during administration. Additionally, they should be reminded to close the valve after each use and when the cylinder is empty to prevent accidental release of gas.

It is important for healthcare providers to emphasize that the use of this gas mixture may be hazardous and is contraindicated in certain situations. Therefore, it should only be administered by or under the supervision of a licensed practitioner who has experience with gas mixtures. Patients should be made aware that the supervising practitioner must be familiar with the indications, effects, dosages, methods, frequency, duration of administration, as well as the associated hazards, contraindications, and necessary precautions.

Lastly, healthcare providers should encourage patients to refer to the Material Safety Data Sheet (MSDS) for detailed information regarding the safe handling and use of the gas mixture.

Storage and Handling

The product is supplied in a manner that ensures safe handling and storage. It is essential to store and use the product in an area with adequate ventilation to prevent the accumulation of potentially harmful gases. Equipment utilized for handling the product must be rated for cylinder pressure to ensure safety during use.

After each use, it is crucial to close the valve and ensure it is securely closed when the cylinder is empty. Users should adhere to the guidelines provided in the Material Safety Data Sheet (MSDS) to ensure proper handling and safety protocols are followed.

Additional Clinical Information

The route of administration for the medication is via respiratory inhalation. There are no additional details available regarding laboratory tests, abuse information, patient counseling, or postmarketing experience.

FDA Insert (PDF)

This document is the official FDA-approved prescribing information for Nitrogen as submitted by Monroe Welding Supply, Inc.. It includes detailed information about indications, dosage, contraindications, warnings, and clinical pharmacology.

View full prescribing information (PDF)